109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE "Renal Cancer 1 " (032422)

Dallas, TX US
March 24, 2022

Course summary

Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
03/24/2022
Course expires: 
03/24/2022
Event starts: 
03/24/2022 - 7:30am CDT
Event ends: 
03/24/2022 - 8:30am CDT
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2022
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Speaker(s)

Hans Hammers, MD PhD

has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Armo Biosciences;.
has a financial relationship (Independent contractor) with BMS;.
has a financial relationship (Independent contractor) with Corvus;.
has a financial relationship (Independent contractor) with Surface Oncology;.
has a financial relationship (Independent contractor) with Merck;.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.